BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34746014)

  • 1. Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis.
    Li R; Song X; Guo Y; Song P; Duan D; Chen ZS
    Front Oncol; 2021; 11():772915. PubMed ID: 34746014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products targeting tumour angiogenesis.
    Lu X; Friedrich LJ; Efferth T
    Br J Pharmacol; 2023 Sep; ():. PubMed ID: 37680009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad targeting of angiogenesis for cancer prevention and therapy.
    Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Cancer Biology, Pathophysiological Development and It's Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy.
    Al-Ostoot FH; Salah S; Khanum SA
    Cancer Invest; 2024 Jun; ():1-46. PubMed ID: 38874308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A; Folkman J
    Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA
    Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
    Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism and its regulation of tumor-induced angiogenesis.
    Gupta MK; Qin RY
    World J Gastroenterol; 2003 Jun; 9(6):1144-55. PubMed ID: 12800214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plants and their active compounds: natural molecules to target angiogenesis.
    Lu K; Bhat M; Basu S
    Angiogenesis; 2016 Jul; 19(3):287-95. PubMed ID: 27154020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature's Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization.
    Kumari R; Syeda S; Shrivastava A
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38425113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural product inhibitors of ocular angiogenesis.
    Sulaiman RS; Basavarajappa HD; Corson TW
    Exp Eye Res; 2014 Dec; 129():161-71. PubMed ID: 25304218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of pro- and anti-angiogenic signals by endothelial cells.
    Kazerounian S; Lawler J
    J Cell Commun Signal; 2018 Mar; 12(1):171-179. PubMed ID: 29264709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Role of Natural Products in Cancer Treatment.
    Ghosh S; Das SK; Sinha K; Ghosh B; Sen K; Ghosh N; Sil PC
    Arch Toxicol; 2024 May; ():. PubMed ID: 38795134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
    Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
    Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
    Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles and role-players in thyroid cancer angiogenesis.
    Rajabi S; Dehghan MH; Dastmalchi R; Jalali Mashayekhi F; Salami S; Hedayati M
    Endocr J; 2019 Apr; 66(4):277-293. PubMed ID: 30842365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current protein-based anti-angiogenic therapeutics.
    Chakrabarti S; Barrow CJ; Kanwar RK; Ramana V; Kanwar JR
    Mini Rev Med Chem; 2014; 14(3):291-312. PubMed ID: 24552262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.